相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
William G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
AHRQ Series Paper 4: Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program
Roger Chou et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)
Initiation of rheumatoid arthritis treatments and the risk of serious infections
Carlos G. Grijalva et al.
RHEUMATOLOGY (2010)
Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial
T. Pincus et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Dose-related patterns of glucocorticoid-induced side effects
D. Huscher et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Serious infections during anti-TNF alpha treatment in rheumatoid arthritis patients
Ennio Giulio Favalli et al.
AUTOIMMUNITY REVIEWS (2009)
Herpes Zoster Risk Factors in a National Cohort of Veterans with Rheumatoid Arthritis
Jay R. McDonald et al.
CLINICAL INFECTIOUS DISEASES (2009)
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti-TNF-α Agents
Anja Strangfeld et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Use of glucocorticoids and risk of infections
Maurizio Cutolo et al.
AUTOIMMUNITY REVIEWS (2008)
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
J. N. Hoes et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Treatment of early rheumatoid arthritis
Patrick Durez et al.
ARTHRITIS AND RHEUMATISM (2007)
Pneumocystis pneumonia associated with infliximab in Japan
Masayoshi Harigai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Johan Askling et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Serious infection following anti-tumor necrosis factor α therapy in patients with rheumatoid arthritis -: Lessons from interpreting data from observational studies
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2007)
Effectiveness of adalimumab for rheumatoid arthritis in patients with a history of TNF-antagonist therapy in clinical practice
S. Bombardieri et al.
RHEUMATOLOGY (2007)
Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis
S. Bernatsky et al.
RHEUMATOLOGY (2007)
Anti-tumor necrosis factor a therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis
Sebastian Schneeweiss et al.
ARTHRITIS AND RHEUMATISM (2007)
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice:: the Research in Active Rheumatoid Arthritis (ReAct) trial
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor α antagonists
Jeffrey R. Curtis et al.
ARTHRITIS AND RHEUMATISM (2007)
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Michael J. Bradburn et al.
STATISTICS IN MEDICINE (2007)
Risk and predictors of infection leading to hospitalisation in a large primary-care-derived cohort of patients with inflammatory polyarthritis
Jarrod Franklin et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Rates and predictors of herpes zoster in patients with rheumatoid arthritis and non-inflammatory musculoskeletal disorders
F. Wolfe et al.
RHEUMATOLOGY (2006)
Antirheumatic drugs and the risk of tuberculosis
Paul Brassard et al.
CLINICAL INFECTIOUS DISEASES (2006)
Safety of extended treatment with anakinra in patients with rheumatoid arthritis
R. M. Fleischmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy - Results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ARTHRITIS AND RHEUMATISM (2006)
Safety of low dose glucocorticoid treatment in rheumatoid arthritis:: published evidence and prospective trial data
JAP Da Silva et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia - Associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2006)
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years - A multicenter, double-blind, placebo-controlled trial
S Wassenberg et al.
ARTHRITIS AND RHEUMATISM (2005)
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate -: A two-year randomized trial
B Svensson et al.
ARTHRITIS AND RHEUMATISM (2005)
Infections in patients with rheumatoid arthritis treated with biologic agents
J Listing et al.
ARTHRITIS AND RHEUMATISM (2005)
A two year randomised controlled trial of intramuscular depot steroids in patients with established rheumatoid arthritis who have shown an incomplete response to disease modifying antirheumatic drugs
EH Choy et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy
F Wolfe et al.
ARTHRITIS AND RHEUMATISM (2004)
A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
P Durez et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis
DM Gerlag et al.
ARTHRITIS AND RHEUMATISM (2004)
Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial
HA Capell et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor α antagonists
L Bergstrom et al.
ARTHRITIS AND RHEUMATISM (2004)
A randomised placebo controlled 12 week trial of budesonide and prednisolone in rheumatoid arthritis
JR Kirwan et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Ileum-targeted steroid therapy in rheumatoid arthritis: double-blind, placebo-controlled trial of controlled-release budesonide
P Sheldon
RHEUMATOLOGY INTERNATIONAL (2003)
Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis
N Tanaka et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2003)
Frequency of infection in patients with rheumatoid arthritis compared with controls - A population-based study
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Predictors of infection in rheumatoid arthritis
MF Doran et al.
ARTHRITIS AND RHEUMATISM (2002)
Systematic reviews in health care - Investigating and dealing with publication and other biases in meta-analysis
JAC Sterne et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
分享论文
